Cite
Tumor-associated antigen-based personalized dendritic cell vaccine in solid tumor patients.
MLA
Wang, Qian-Ting, et al. “Tumor-Associated Antigen-Based Personalized Dendritic Cell Vaccine in Solid Tumor Patients.” Cancer Immunology, Immunotherapy, vol. 69, no. 7, July 2020, pp. 1375–87. EBSCOhost, https://doi.org/10.1007/s00262-020-02496-w.
APA
Wang, Q.-T., Nie, Y., Sun, S.-N., Lin, T., Han, R.-J., Jiang, J., Li, Z., Li, J.-Q., Xiao, Y.-P., Fan, Y.-Y., Yuan, X.-H., Zhang, H., Zhao, B.-B., Zeng, M., Li, S.-Y., Liao, H.-X., Zhang, J., & He, Y.-W. (2020). Tumor-associated antigen-based personalized dendritic cell vaccine in solid tumor patients. Cancer Immunology, Immunotherapy, 69(7), 1375–1387. https://doi.org/10.1007/s00262-020-02496-w
Chicago
Wang, Qian-Ting, Ying Nie, Sheng-Nan Sun, Tao Lin, Ru-Jin Han, Jun Jiang, Zhe Li, et al. 2020. “Tumor-Associated Antigen-Based Personalized Dendritic Cell Vaccine in Solid Tumor Patients.” Cancer Immunology, Immunotherapy 69 (7): 1375–87. doi:10.1007/s00262-020-02496-w.